Annual Drug Patent Expirations for NEXTERONE
Nexterone is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug.
Drug patent litigation for NEXTERONE.
This drug has forty-seven patent family members in twenty countries.
The generic ingredient in NEXTERONE is amiodarone hydrochloride. Two suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
